Metastasis-Free Survival Viable Endpoint for Prostate Cancer Trials
Metastasis-free survival could be a surrogate endpoint for OS in clinical trials designed to evaluate adjuvant therapy options for patients... Read More
Platinum-Based Chemotherapy Shows Efficacy in BRCA2-Mutated Prostate Cancer
A small group of men with metastatic, castration-resistant prostate cancer who carried a BRCA2 mutation responded favorably to platinum-based chemotherapy... Read More
Diabetes Does Not Affect Overall Survival in Prostate Cancer
Among men with prostate cancer, diabetes status did not significantly affect 5-year overall survival, according to findings published in Endocrine... Read More
Memorial Sloan Kettering Cancer Center to Study Photodynamic Therapy for Multiple Tumor Types
Researchers at Memorial Sloan Kettering Cancer Center have initiated several studies to assess photodynamic therapy for patients with prostate, esophageal,... Read More
Direct-to-Consumer Genetic Testing Does Not Improve Habits in High-Risk Adults
Most adults who received elevated direct-to-consumer personal genomic testing to detect risk for single nucleotide polymorphism–based cancer were not more... Read More
Five-Tiered Gleason Grouping System Predicts Prostate Cancer Mortality
Researchers successfully validated the five-tiered Gleason Grade Grouping system for predicting mortality among men with prostate cancer, according to results... Read More
Novel Technique May Help Some Patients with Prostate Cancer Avoid Common Adverse Events
MRI–guided focal therapy, a novel tumor-destroying technology, is being investigated at Brigham and Women’s Hospital to spare patients with prostate... Read More